- 现金
- 12001 元
- 精华
- 76
- 帖子
- 8457
- 注册时间
- 2002-8-30
- 最后登录
- 2010-2-5
|
10楼
发表于 2004-4-17 20:34
[B]REFERENCES[/B]
Zuckerman JN, Zuckerman AJ. The epidemiology of hepatitis B. Clin Liver Dis 1999;3:179-87.
Goldstein ST, Alter MJ, Williams IT, Moyer LA, Judson FN, Mottram K, et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis 2002;185:713-9.
Ott MJ, Aruda M. Hepatitis B vaccine. J Pediatr Health Care 1999;13:211-6.
Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002;51(RR-6):1-78.
Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-45.
Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000--summary of a workshop. Gastroenterology 2001;120:1828-53.
Viral hepatitis B. Accessed September 17, 2003, at: http://www.cdc.gov/ncidod/diseases/hepatitis/b/Bserology.htm.
Befeler AS, Di Bisceglie AM. Hepatitis B. Infect Dis Clin North Am 2000;14:617-32.
Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2001;34:1225-41.
Perrillo RP. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001;120:1009-22.
Hepatitis B vaccination--United States, 1982-2002. MMWR Morb Mortal Wkly Rep 2002;51:549-52,563.
Kahn J. Preventing hepatitis A and hepatitis B virus infections among men who have sex with men. Clin Infect Dis 2002;35:1382-7.
Euler GL, Copeland JR, Rangel MC, Williams WW. Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigen-positive women. Pediatr Infect Dis J 2003;22:123-9.
Hunt CM, Sharara AI. Liver disease in pregnancy. Am Fam Physician 1999;59:829-36.
Hill JB, Sheffield JS, Kim MJ, Alexander JM, Sercely B, Wendel GD. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 2002;99:1049-52.
Malik AH, Lee WM. Chronic hepatitis B virus infection: treatment strategies for the next millennium. Ann Intern Med 2000;132:723-31.
Adefovir (Hepsera) for chronic hepatitis B infection. Med Lett Drugs Ther 2002;44:105-6.
Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998;339:61-8.
Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999;341:1256-63.
Jonas MM, Kelley DA, Mizerski J, Badia IB, Areias JA, Schwarz KB, et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 2002;346:1706-13.
Lau DT, Khokhar MF, Doo E, Ghany MG, Herion D, Park Y, et al. Long-term therapy of chronic hepatitis B with lamivudine. Hepatology 2000;32(4 pt 1):828-34.
Perrillo R, Schiff E, Yoshida E, Statler A, Hirsch K, Wright T, et al. Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology 2000;32:129-34.
Baker R. Gilead Sciences wins FDA approval for Hepsera (adefovir dipivoxil). Accessed July 11, 2003, at: http://www.hivandhepatitis.com/hep_b/ news/092302a.html.
Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med 2003; 348:800-7.
Marcellin P, Chang TT, Lim SG, Tong MJ, Sievert W, Shiffman ML, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 2003;348:808-16.
Ascherio A, Zhang SM, Hernan MA, Olek MJ, Coplan PM, Brodovicz K, et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001;344:327-32.
|
|